![image2](https://www.med.unc.edu/microimm/wp-content/uploads/sites/745/2018/06/baric-colleagues-immunotherapy-for-zika-image2.jpeg)
Research from the labs of M&I Professors Ralph Baric, Mark Heise, and Aravinda de Silva demonstrates how cross-reacting antibodies from convalescent dengue patients may help protect against Zika virus:
Antibodies from dengue virus survivors can be used to prevent Zika infection